+Compare
BMY
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
168.48B

BMY Price Prediction, Bristol-Myers Squibb Co AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
BMY Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Nov 25, 2022

BMY sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BMY moved above the 200-day moving average on November 10, 2022. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMY advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 289 cases where BMY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BMY moved out of overbought territory on November 11, 2022. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on November 11, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on BMY as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BMY turned negative on November 14, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.157) is normal, around the industry mean (5.298). P/E Ratio (25.840) is within average values for comparable stocks, (33.260). Projected Growth (PEG Ratio) (2.437) is also within normal values, averaging (4.360). Dividend Yield (0.027) settles around the average of (0.026) among similar stocks. P/S Ratio (3.681) is also within normal values, averaging (4.174).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. BMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

BMY is expected to report earnings to fall 13.07% to $1.73 per share on February 02

Bristol-Myers Squibb Co BMY Stock Earnings Reports
Q4'22
Est.
$1.73
Q3'22
Beat
by $0.16
Q2'22
Beat
by $0.16
Q1'22
Beat
by $0.05
Q4'21
Beat
by $0.03
The last earnings report on October 25 showed earnings per share of $1.99, beating the estimate of $1.83. With 596.06K shares outstanding, the current market capitalization sits at 168.48B.
AI
A.I.Advisor
published Dividends

BMY paid dividends on November 01, 2022

Bristol-Myers Squibb Co BMY Stock Dividends
А dividend of $0.54 per share was paid with a record date of November 01, 2022, and an ex-dividend date of October 06, 2022. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Pfizer (NYSE:PFE), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 80.86B. The market cap for tickers in the group ranges from 226K to 463.39B. JNJ holds the highest valuation in this group at 463.39B. The lowest valued company is NEWG at 226K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 3%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was -3%. CRXTQ experienced the highest price growth at 61%, while SCLX experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -61%. For the same stocks of the Industry, the average monthly volume growth was -63% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 26
P/E Growth Rating: 49
Price Growth Rating: 48
SMR Rating: 44
Profit Risk Rating: 100
Seasonality Score: -7 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
430 East 29th Street
Phone
+1 212 546-4000
Employees
32200
Web
https://www.bms.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RITM9.010.14
+1.58%
Rithm Capital Corp
RGF7.300.11
+1.53%
Real Good Food Company (The)
DH11.100.13
+1.19%
Definitive Healthcare Corp
RELX28.090.10
+0.36%
Relx PLC
GWRS12.64-0.19
-1.48%
Global Water Resources

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with MRK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then MRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
+0.13%
MRK - BMY
62%
Loosely correlated
+0.64%
LLY - BMY
54%
Loosely correlated
+0.98%
JNJ - BMY
52%
Loosely correlated
+0.13%
PFE - BMY
49%
Loosely correlated
+0.74%
ABBV - BMY
48%
Loosely correlated
+0.14%
More